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Determining the Biosynthetic Sequence in the Early Steps of
the Fumonisin Pathway by Use of Three Gene-Disruption
Mutants of Fusarium verticillioides
RAVI S. BOJJA,† RONALD L. CERNY,† ROBERT H. PROCTOR,‡
LIANGCHENG DU*,†

AND

Chemistry Department, University of NebraskasLincoln, Lincoln, Nebraska 68588-0304, and
National Center for Agricultural Utilization Research, Agricultural Research Service,
U.S. Department of Agriculture, 1815 North University Street, Peoria, Illinois 61604-3999

Fumonisins are polyketide-derived mycotoxins produced by Fusarium verticillioides, a fungal pathogen
of corn plants. Although a gene cluster for the biosynthesis of fumonisins has been cloned, the
biosynthetic pathway is still not clear. We have used three gene-disrupted mutants, designated
∆FUM1, ∆FUM6, and ∆FUM8, to study the early steps of the pathway. Fumonisins were not produced
in single-strain cultures of the ∆FUM1, ∆FUM6, and ∆FUM8 mutants. However, fumonisins were
produced by ∆FUM1 or ∆FUM8 mutants when they were cocultured with the ∆FUM6 mutant. No
fumonisins were produced when the ∆FUM1 and ∆FUM8 mutants were cocultured. These results
suggest that the ∆FUM6 mutant produces a fumonisin intermediate that can be further metabolized
by fumonisin biosynthetic enzymes in the ∆FUM1 and ∆FUM8 mutants. To isolate the potential
intermediates produced by ∆FUM6, we followed a time course of cocultures of the ∆FUM1 and ∆FUM6
and the ∆FUM8 and ∆FUM6 mutants. Liquid chromatographic-mass spectrometric data suggested
that metabolites having the general carbon skeleton of fumonisins with 1-4 hydroxyl groups were
accumulated over a 7-day period. These results indicate that fumonisin biosynthesis starts with Fum1pcatalyzed carbon-chain assembly followed by the Fum8p-catalyzed alanine condensation. The resulting
product then can be further oxidized by Fum6p and other enzymes.
KEYWORDS: Fumonisin; Fusarium verticillioides; mycotoxin; biosynthesis

INTRODUCTION

Fumonisins are polyketide-derived mycotoxins produced by
the filamentous fungus Fusarium Verticillioides (Sacc.) Nirenberg (synonym F. moniliforme, teleomorph Gibberella moniliformis, synonym G. fujikuroi mating population A) (1, 2). The
fungus is a widespread pathogen of corn plants, on which it
causes ear and stalk rots (3). Fumonisins cause several fatal
animal diseases, including leukoencephalomalacia in horses,
pulmonary edema in swine, and cancer in rats and mice (1, 4,
5). In addition, fumonisins are suspected to cause human
esophageal cancer (1).
Wild-type strains of F. Verticillioides produce predominantly
four B-series fumonisins (B1, B2, B3, and B4), with fumonisin
B1 making up to approximately 70% of the total content (2).
These compounds have a linear 20-carbon backbone with
hydroxyl, methyl, and tricarballylic acid moieties at various
positions along the backbone (Figure 1) (6). The backbone
originates from a C18 polyketide chain and one amino acid.
* To whom correspondence should be addressed: telephone 402-4722998; fax 402-472-9402; e-mail ldu@unlserve.unl.edu.
† University of NebraskasLincoln.
‡ U.S. Department of Agriculture.

Figure 1. Chemical structures of B-series fumonisins.

Isotope feeding experiments have shown that the carbons 3-20
of the backbone are derived from acetate and that the amino
group and C-1 and C-2 are derived from alanine (7, 8). The
origin of several moieties attached to the backbone has also
been studied. The two methyl groups on C-12 and C-16 are
derived from methionine (9). The hydroxyl group on C-3 is
from an acetate-derived carbonyl group, whereas the hydroxyl
groups on C-5, C-10, C-14, and C-15 are likely from molecular
oxygen (10). The origin of the tricarballylic acid is generally
believed to be from the citric acid cycle (7). Despite these
previous biochemical studies, however, little is known about
the biosynthetic sequence for these individual steps.
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Recently, a 15-gene cluster (FUM1 and FUM6-FUM19)
required for the biosynthesis of fumonisins in F. Verticillioides
was cloned and characterized (11-13). The identification of
this cluster has facilitated direct studies of the biosynthetic genes
by genetic and biochemical approaches. Among the FUM genes,
FUM13 has been characterized by a genetic approach (14).
Butchko et al. (14) found that a FUM13-deleted mutant
accumulated the C-3 keto form of fumonisins B3 and B4,
indicating that this gene encodes a C-3 keto reductase of
fumonisins (14). More recently, Butchko et al. (15) generated
a FUM3 (also FUM9) deletion mutant and showed that this gene
is required for the C-5 hydroxylation of fumonisins. We also
obtained biochemical data via heterologous expression in yeast
that demonstrated that FUM3 encodes a 2-ketoglutarate-dependent dioxygenase that catalyzes the conversion of fumonisin
B3 to B1, directly confirming that Fum3p catalyzes the C-5
hydroxylation (16). Several other FUM disruption mutants,
including ∆FUM1, ∆FUM6, ∆FUM8, ∆FUM17, ∆FUM18, and
∆FUM19, have also been generated by Proctor and co-workers
(11-13). The first three mutants did not accumulate any
identifiable intermediates that could have provided additional
information about the function of these genes, while the latter
mutants were not or only subtly affected in their ability to
produce fumonisins. Therefore, additional and alternative approaches are needed to study the functions of these genes. Here,
we present data obtained from coculture experiments using three
FUM disruption mutants, ∆FUM1, ∆FUM6, and ∆FUM8. The
results in this study provide evidence for the order of some of
the early biochemical reactions in the fumonisin biosynthetic
pathway.
MATERIALS AND METHODS
Materials and Growth of Fungi. Standard fumonisin B1, B2, B3,
and B4 were gifts from Dr. Ronald D. Plattner (USDA, Peoria, IL) or
purchased from Promec Unit, The Medical Research Council, South
Africa. Corn and corn meal were purchased from a local store. Wildtype strain F. Verticillioides A0149 was provided by Dr. Gilchrist
(University of California, Davis). General fungal growth was in GYP
medium (2% glucose, 1% peptone, and 0.3% yeast extract) (11).
Conidia were collected from V-8 juice agar plates after 3 weeks growth
as described (11). CMK (cracked maize kernels) or GYAM medium
(0.12 M glucose, 50 mM malic acid, 8.0 mM l-asparagine, 1.7 mM
NaCl, 4.4 mM K2HPO4, 2.0 mM MgSO4, 8.8 mM CaCl2, and 0.05%
yeast extract, adjusted to pH 3.0 with HCl) were used for fumonisin
production (10, 11). CMK was soaked in water for 24 h and thoroughly
washed with water prior to autoclaving to remove any potential
fumonisin contamination on the kernels. No fumonisin was detected
in the medium (by HPLC-ELSD and LC-MS analysis, see below).
Coculture of Mutants. Gene-disruption mutants ∆FUM1 (originally
designated ∆FUM5, strain GFA2364) and ∆FUM6 (strain GFA3075)
were previously generated by replacing internal fragments of FUM1
and FUM6, respectively, with the hygromycin marker gene (Hyg) (11,
13). Mutant ∆FUM8 (strain GFA3245) was also previously generated
but via additive gene disruption of the FUM8 gene, which resulted in
a mutant containing two incomplete copies of the FUM8 coding region
(13). Approximately 8 × 107 conidia of mutant strains were used to
inoculate CMK (5 g) medium or liquid GYAM (10 mL, containing
7% corn meal). Mycelia plugs from V8 plates were also used for
inoculations in several batches. The cultures were allowed to grow for
2-3 weeks with occasional shaking to allow even distribution of the
cultures. In the time-course studies, a total of eight CMK (5 g) cultures
were inoculated with a 3:1 mixture of ∆Fum6 + ∆Fum5 or ∆Fum6 +
∆Fum8 (approximately 6 × 1010 conidia). Two milliliters of sterilized
distilled water was added to the media after inoculation. The wildtype strain and individually inoculated mutants served as controls. The
cultures were harvested from the 3rd to the 7th day by the extraction
of chloroform (10 mL). Three duplicated samples were obtained for
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each time point. The extracts were dried in a rotary evaporator and
redissolved in 1 mL of 50% methanol for analysis by HPLC-ELSD
and LC-MS.
Metabolite Extraction. Initially, the cultures of mutants on CMK
medium were extracted with H2O or CH3OH/CHCl3 (1:1 v/v) separately,
to get all possible metabolites accumulated in the mutants. After the
metabolite pattern in the extracts was checked by HPLC analysis,
cultures from CMK were extracted with a mixture of CHCl3/CH3OH/
H2O (1:1:1 v/v/v) in all subsequent experiments. Typically, a 5 g CMK
culture was soaked in 15 mL of solvent overnight and filtered through
Whatman no. 1 paper. The filtrate was dried in a rotary evaporator
and resuspended in 2.5 mL of water. This solution was filtered through
a 0.2 µm syringe filter (Nalge Company, New York) and directly
subjected to HPLC analysis. For culture from GYAM, the 10-mL
medium was filtered through Whatman no. 1 paper, and 3 g of
Amberlite XAD-4 beads was added to the resulting solution, which
was gently shaken overnight. The XAD beads were then washed with
water, and metabolites were eluted from the beads with 100% methanol.
The eluted solution was dried in a rotary evaporator and redissolved
in water. This solution was filtered and subjected to HPLC analysis.
Analytical Methods. The high-performance liquid chromatography
(HPLC) system was a ProStar, Model 210 from Varian (Walnut Creek,
CA) with a 250 × 4.6 mm i.d., 5 µm, Alltima C18LL column (Alltech,
Deerfield, IL). The mobile phases were (A) water/TFA (100:0.025 v/v)
and (B) acetonitrile/TFA (100:0.025 v/v) with a gradient of 0 to 20%
B in A in the first 5 min, 20% to 40% B in A from 5 to 10 min, 40%
to 80% B in A from 10 to 15 min, 80% to 80% B in A from 15 to 20
min, and 80% to 0% B in A from 20 to 25 min. The flow rate was 1.0
mL/min, and a 40 µL portion was injected in all analytical experiments.
The conditions set for light scattering detection on an ELSD2000
(Alltech, Deerfield, IL) were 45 °C of drift tube temperature, 2.0 L/min
of gas flow, and gain value of 1 in the impactor-on mode. For
preparative HPLC, the respective fractions were collected directly from
the column according to their retention times. For liquid chromatography-mass spectrometry (LC-MS), a 250 × 1 mm i.d., 5 µm, RFC18
Vydac column (Vydac) was used. The solvent systems were (A) water/
formic acid (100:0.1 v/v) and (B) 95% acetonitrile/formic acid (100/
0.1 v/v). The flow rate was 0.05 mL/min, and the injection volume
was 50 µL. All positive electrospray spectra were acquired on a VG
Platform II mass spectrometer or a Micromass Q-Tof (Manchester,
U.K.).
RESULTS AND DISCUSSION

Analysis of Metabolites in Mutants ∆FUM1, ∆FUM6, and
∆FUM8. Cultures were extracted with chloroform/methanol or
water. The chloroform/methanol extracts formed two layers after
centrifugation, with the upper layer being methanol, together
with water from the culture medium, and the lower layer being
chloroform. While the methanol layer or the water-alone extracts
did not contain any obvious new peaks on HPLC-ELSD when
compared to that from the wild-type strain, the chloroform layer
gave approximately 8-15 peaks (13-17 min retention times)
on HPLC-ELSD (data not shown). Most of the peaks were
common to all the mutants, suggesting that the compounds may
not be directly related to the mutated genes. However, extracts
from ∆FUM6 and ∆FUM8 contained 1-2 peaks that were not
present in extracts of ∆FUM1 or wild-type strain (data not
shown). The results suggest that potential intermediates could
be present in ∆FUM6 and ∆FUM8 mutants. The yield of the
new peaks was low, and attempts to directly characterize them
were not successful. To understand the role of the mutated genes
in the biosynthetic pathway of fumonisins, we took an alternative
approach, the coculturing of mutants.
Complementation of ∆FUM6 by Coculture with ∆FUM1
or ∆FUM8. HPLC analysis of extracts from wild-type F.
Verticillioides revealed one major peak with a retention time of
16.48 min, which is the same as that of standard fumonisin B1
(Figure 2A), and 5-6 minor peaks in the same region. Among
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Figure 2. HPLC-ELSD analysis of extracts from 2-week-old CMK cultures.

(A) Wild-type F. verticillioides; (B) coculture of mutants ∆FUM1 and
∆FUM6.

these minor peaks, two with retention times of 17.55 and 18.04
min coeluted with the fumonisin B3 and B2 standards, respectively. The identity of these peaks was confirmed by LC-MS
analysis. Under the experimental conditions used, the major peak
had a retention time of 8.40 min on LC-MS and a [M + H]+ of
m/z 722.8, which are the same as those of standard fumonisin
B1 (data not shown). The two minor peaks had retention times
of 8.72 and 8.88 min, respectively. They have the same [M +
H]+ of m/z 706.9, which is the same as those of fumonisin B3
and B2 (data not shown). The estimated yield of fumonisins in
the wild type was 1100-1700 µg of fumonisin B1, 320-410
µg of B2, and 690-810 µg of B3 per gram of CMK solid culture
after 2 weeks of growth.
In contrast to cultures of individual FUM mutants, cocultures
of some of the mutants produced fumonisins. According to
HPLC-ELSD analysis, extracts of cocultures of the ∆FUM1
and ∆FUM6 mutants grown for 2-3 weeks in either CMK or
GYAM contained metabolites that coeluted with the fumonisin
B1 and B3 standards (Figure 2B). LC-MS analysis confirmed
the presence of fumonisin B1 and B3 in the ∆FUM1 + ∆FUM6
coculture (Figure 3A). The estimated yield of fumonisins in
the cocultures was 820-1100 µg of B1, 170-190 µg of B2,
and 310-370 µg of B3 per gram of CMK solid culture or 130140 µg of B1, 31-39 µg of B2, and 68-81 µg of B3 per milliliter
of GYAM liquid culture, after 2 weeks of growth. A similar
result was obtained when the ∆FUM6 and ∆FUM8 mutants
were cocultured (Figure 3C) but not when the ∆FUM1 and
∆FUM8 mutants were cocultured (Figure 3B). Thus, fumonisin
production was restored only in cocultures that included the
∆FUM6 mutant.
The coculture results implied that a putative intermediate(s)
produced by the ∆FUM6 mutant was secreted into the culture
medium, taken up by ∆FUM1 or ∆FUM8 mutant, and subsequently metabolized to fumonisins. This process did not occur
in cocultures of the ∆FUM1 and ∆FUM8 mutants. The results
suggest that the blockage of the biosynthetic pathway at the
FUM1 and FUM8 stage does not result in the accumulation of
intermediates. FUM1 encodes a polyketide synthase catalyzing
the assembly of the carbon backbone of fumonisins (11).
According to the paradigm of polyketide synthase-catalyzed
reactions, all intermediates will be covalently attached to the
enzyme throughout the entire process of chain elongation (17).
A disruption of the polyketide synthase gene (FUM1) would
result in no carbon chain assembly, whereas a disruption of a
step immediately downstream of the polyketide synthase would
result in the accumulation of the covalently bound carbon chains.

Figure 3. LC-MS analysis of extracts from 2-week-old CMK cocultures

of mutants. (A) Total ion current (TIC) of mutants ∆FUM1 and ∆FUM6
coculture; (B) TIC of mutants ∆FUM1 and ∆FUM8 coculture; (C) TIC of
mutants ∆FUM6 and ∆FUM8 coculture.

Normally, such bound intermediates could not be released into
the media unless a thioesterase domain (or a functional
equivalent) is present in the polyketide synthase (17). Fum1p
does not have such a chain-releasing domain (11). FUM8
encodes a serine palmitoyltransferase-like enzyme, which is the
obvious candidate for catalyzing the condensation between
alanine and the polyketide carbon chain (dimethyl stearate) of
fumonisins. Furthermore, it is possible that the Fum8p includes
a polyketide chain-releasing mechanism (see below). FUM6
encodes a cytochrome P450-dependent oxygenase, which is
likely involved in the modification of the carbon backbone of
fumonisins. The modification of a polyketide chain could take
place before or after its release from the synthase (18, 19).
Because fumonisins were produced in cocultures only when the
∆FUM6 mutant was present, the data support that the Fum8pcatalyzed condensation of dimethyl stearate and alanine precedes
the Fum6p-catalyzed oxidation, i.e., the chain release precedes
the chain modification. Therefore, the biosynthetic sequence in
these early steps of fumonisin pathway is likely to be Fum1pFum8p-Fum6p.
Potential Intermediates. To further understand the nature
of the putative intermediates accumulated in ∆FUM6, we carried
out a series of feeding experiments. We envisage that the feeding
of the intermediate compounds isolated from the ∆FUM6 mutant
to the ∆FUM1 or ∆FUM8 mutant could result in the fumonisin
production. However, feeding experiments using the total extract
as well as the individual HPLC fractions failed to produce
consistent results, suggesting that the potential intermediates
could be very unstable when isolated. Because the coculture
experiments consistently produced fumonisins, ∆FUM6 must
produce one or more intermediates. We speculated that if we
followed a time course of the ∆FUM6 and ∆FUM1 coculture
or ∆FUM6 and ∆FUM8 coculture, we would be able to detect
an intermediate(s). According to HPLC-ELSD analysis, beginning 3 days after the start of the ∆FUM6 and ∆FUM1 coculture
or ∆FUM6 and ∆FUM8 coculture, 2-3 new peaks appeared
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Figure 4. LC-MS analysis of the putative intermediates that accumulated

in the cocultures of mutants. Extracts from the ∆FUM6 and ∆FUM1
coculture were analyzed by HPLC-ELSD over a 7-day time course, and
the regions that showed decreased or increased peak intensities on HPLCELSD were collected for LC-MS analysis. (A) Total ion current (TIC) of
extract from the ∆FUM6 and ∆FUM1 coculture at the 7th day; (B)
electrospray mass spectrum time-of-flight (TOF) analysis of the peak at
12.4 min in panel A; (C) electrospray mass spectrum TOF analysis of
the peak at 13.1 min in panel A.

at retention times of 17-20 min. More interestingly, the intensity
of some of these peaks gradually decreased over the time course,
whereas others gradually increased (data not shown). We
subsequently collected the peaks at this region from HPLC and
analyzed them by LC-MS. The results showed that four major
peaks were present in the 10-15 min region (Figure 4A). The
peak at 12.4 min gave a [M + H]+ of m/z 342.3, whereas the
peaks at 13.1, 13.9, and 14.1 min had the same [M + H]+ of
m/z 358.4. An analysis of the mass spectra of the peak at 12.4
min (Figure 4B) and 13.1 min (Figure 4C) suggested that 1-2
hydroxyl groups are likely present in the molecules. A loss of
one hydroxyl group (as a water molecule) from the m/z 342.4
ion would give rise to the m/z 324.4 ion in Figure 4B, and a
loss of one or two hydroxyl groups from the m/z 358.5 ion would
account for the m/z 340.5 or 322.5 ion, respectively, in Figure
4C. We further examined the peaks using MS-MS analysis. The
results not only confirmed the presence of hydroxyl groups in
the molecules but also indicated the presence of a long aliphatic
chain in the molecules as evidenced by the characteristic
fragmentation pattern of peaks with a 14 mass-unit difference
(for the CH2 groups) (data not shown). Minor peaks in this
region gave [M + H]+ of m/z 340.3, 374.4, and 390.4 (data not
shown). These masses are coincident with those of compounds
that have the general carbon skeleton of fumonisins but with
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various numbers of hydroxyl groups (Figure 5). The first major
peak has a [M + H]+ of m/z 342.3, which is the expected mass
for the 3-ol product (2-amino-3-hydroxy-12,16-dimethylicosane)
(Figure 5). This product could be generated by a condensation
between the putative 20-carbon polyketide and alanine followed
by reduction of the 3-keto function to 3-ol. The putative 3-keto
compound (2-amino-3-oxo-12,16-dimethylicosane) has a calculated mass of 339.6. Only a minor peak of [M + H]+ of m/z
340.3 was found in the samples, suggesting that the 3-keto
product is readily reduced by a reductase, presumably Fum13p
(14), in the ∆FUM6 mutant. The [M + H]+ of m/z 358.4 of the
other three major peaks is consistent with the addition of a
second hydroxyl group to the 3-ol product to form diol products.
Since they had the same mass but different retention times, the
diol products are likely to be isomers resulting from regioselective (e.g., 14-ol versus 15-ol) and/or stereoselective (e.g.,
epimers) hydroxylations. Finally, the presence of minor products
with [M + H]+ of m/z 374.4 and 390.4 suggests that a third
and fourth hydroxyl group were added to the carbon backbone
to produce triol and tetraol products, respectively (see Figure 5
for structures).
The identification of the putative fumonisin intermediates in
the ∆FUM6 and ∆FUM1 coculture and ∆FUM6 and ∆FUM8
coculture has significant implications in the understanding of
the fumonisin biosynthetic pathway. First, a compound with a
single carbon-carbon bond between C-14 and C-15 is probably
the direct substrate for the Fum6p-catalyzed hydroxylation. It
was previously implied that the vicinal diol at C-14 and C-15
could be generated by epoxide hydrolation (20). If this were
the case, Fum6p would catalyze an epoxidation at C-14 and
C-15, and this would require a substrate with a double bond
between C-14 and C-15. Moreover, opening the epoxide ring
to generate the vicinal diol would also require an epoxide
hydrolase. However, no epoxide hydrolase gene was found in
the FUM gene cluster (12). Because the four major peaks present
in the coculture do not suggest the presence of a double bond
or a vicinal diol at C-14 and C-15, our results provide evidence
for a direct hydroxylation of a saturated carbon chain, rather
than a ring opening of an epoxide intermediate. Second, the
coexistence of multiple components with the same mass for the
diol compounds suggests that the oxidation enzymes may not
have a strict substrate specificity. In addition to FUM6, there
are two other P450 genes (FUM12 and FUM15) found in the
FUM gene cluster (12). The latter two P450 enzymes may be
responsible for the addition of the third hydroxyl group (e.g.,
in 3,14,15-triol product) or the fourth hydroxyl group (e.g., in
3,10,14,15-tetraol product) (Figure 5). Although the exact
regiospecificity of P450 enzymes is not clear, our data suggest
that the oxidation steps could take place at various stages in
the biosynthesis of fumonisins.
The cloning of the FUM gene cluster and successful isolation
of biosynthetic intermediates from mutants ∆FUM9 and ∆FUM13
have provided important information for the biosynthetic
mechanism of fumonisins (11-15). FUM3 encodes a dioxygenase that catalyzes the C-5 hydroxylation of fumonisins (15,
16), while FUM13 encodes a keto reductase that catalyzes the
reduction of C-3 carbonyl to a hydroxyl (14). Only derivatives
of fumonisin B3 and B4, but not fumonisin B1 and B2,
accumulated in ∆FUM3 and ∆FUM13 mutants. This indicates
that the steps catalyzed by these two enzymes may occur later
in the biosynthetic pathway or that downstream enzymes are
able to process at least some “unnatural” substrates (e.g., the
C-3 keto form) to fumonisin B3 and B4. In this study, we have
successfully applied the coculture approach to obtain biosyn-
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Figure 5. Proposed biosynthetic pathway for fumonisins. Molecular weights for putative intermediates were included to account for the LC-MS data

observed in Figure 4. For the structure of fumonisins B1, B2, B3, and B4, see Figure 1. SAM, S-adenosylmethionine.

thetic information from mutants that do not accumulate any
isolatable intermediate. By following a time course of coculture,
rather than an end product of individual culture of the mutants,
we were able to identify a number of putative intermediates.
The data provide evidence for the sequence of enzymatic steps
in fumonisin biosynthesis. On the basis of these data and those
from previous studies (11-16), we propose a biosynthetic
pathway as depicted in Figure 5. The biosynthesis starts with
the Fum1p-catalyzed carbon chain assembly from one molecule
of acetyl CoA, eight molecules of malonyl CoA, and two
molecules of methionine (in S-adenosyl form). The C18 polyketide
chain is released from the enzyme by a nucleophilic attack of
a carbanion, which is derived from R-carbon of alanine by
decarboxylation, on the carbonyl carbon of polyketide acyl
chain. This step is catalyzed by a pyridoxal 5′-phosphate- (PLP-)
dependent aminoacyl transferase Fum8p (13, 14). The resultant
3-keto intermediate is then stereospecifically reduced to a
3-hydroxyl product by reductase Fum13p (14). Subsequent
oxidations at C-14 and C-15 positions by cytochrome P450dependent oxygenases Fum6p, Fum12p, or Fum15p, tricarballylic esterification of the hydroxyl groups on C-14 and C-15
by acyltransferase Fum14p, and C-5 hydroxylation by 2-ketoglutarate-dependent dioxygenase Fum3p furnish the biosynthesis
of fumonisins (Figure 5). The tricarballylic moieties are most
likely derived from the citric acid cycle (e.g., aconitic acid) (7),
and their addition to the carbon backbone may involve Fum7p,
Fum10p, Fum11p, and Fum14p (Butchko, Plattner, and Proctor,
unpublished data). A reduction of aconitate by Fum7p followed
by a thioesterification with CoA as cosubstrate, catalyzed by
Fum10p, would produce an activated acyl-S-CoA of tricarballylic acid. Fum14p then catalyzes the transfer of tricarballylic
acyl-CoA to the diols on C-14 and C-15 to form the diesters of

fumonisins. The validation of the sequence of latter reactions
in the fumonisin biosynthetic pathway will require further studies
with both genetic and biochemical approaches.
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